Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,281 public trials 1,202 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Recruiting

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

NCT06956690

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +22 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Indianapolis, Indiana, United States
  • Research Site Farmington Hills, Michigan, United States
  • Research Site Dallas, Texas, United States
View Trial Details
Recruiting

Repositioning Immunotherapy in VetArans With Lung Cancer

NCT06275360

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • VA Connecticut Healthcare System West Haven Campus, West Haven, CT West Haven, Connecticut, United States
  • VA Central Office, Washington, DC Washington D.C., District of Columbia, United States
  • Richard L. Roudebush VA Medical Center, Indianapolis, IN Indianapolis, Indiana, United States
  • VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor, Michigan, United States
View Trial Details
Recruiting

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

NCT03808337

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +16 more
Locations
  • Natera, Inc. (Data and Specimen Analysis Only) San Carlos, California, United States
  • Hartford Healthcare Hartford, Connecticut, United States
  • WCHN Norwalk Hospital - Data Collection Norwalk, Connecticut, United States
  • Baptist Alliance - McI Miami, Florida, United States
View Trial Details
Recruiting

A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors

NCT07361562

Conditions
Advanced Solid Tumor, Adult, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
Locations
  • START Midwest Grand Rapids, Michigan, United States
  • NYU Langone New York, United States
  • Tennessee Oncology Nashville, Tennessee, United States
  • NEXT Oncology Texas Austin, Texas, United States
View Trial Details
Recruiting

A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN1)

NCT06905197

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health New York, United States
  • Herbert Irving Comprehensive Cancer Center New York, United States
  • Virginia Cancer Specialist (NEXT Oncology-Virginia) Fairfax, Virginia, United States
  • Blacktown Hospital Blacktown, New South Wales, Australia
View Trial Details
Recruiting

REPotrectinib in ROS1-positive Non-small Cell Lung Cancer Patients With Active Brain mEtastasis

NCT06315010

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +16 more
Locations
  • Medizinische Universität Graz Graz, Austria
  • Medical University of Vienna Vienna, Austria
  • Ludwig-Maximilians-University Munich München, Germany
  • Hospital de Vinalopó Elche, Alicante, Spain
View all 16 locations
View Trial Details

Related conditions